SHH ยท Financial Statements

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) Financial Statements

$41.55 SHH: 600329.SS Market Cap $31.44B

Full income statement, balance sheet, and cash flow statement for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
600329.SS Overview 600329.SS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.